[1] 花迎杰,刘利鹏,边琳. 系统性红斑狼疮合并低凝血酶原血症-狼疮抗凝物综合征一例[J]. 中华医学杂志,2018,98(8):633. Hua YJ,Liu LP,Bian L.A case of systemic lupus erythematosus complicated with hypoproteinemia-lupus anticoagulant syndrome[J]. Natl Med J China,2018,98(8):633. [2] Appleton C,Gillam L,Koulogiannis K.Cardiac tamponade[J]. Cardiol Clin,2017,35(4):525-537. [3] Chaves RCF,Rabello Filho R,Timenetsky KT,et al.Extracor-poreal membrane oxygenation:a literature review[J]. Rev Bras Ter Intensiva,2019,31(3):410-424. [4] McMichael ABV,Ryerson LM,Ratano D,et al. 2021 ELSO adult and pediatric anticoagulation guidelines[J]. ASAIO J,2022,68(3):303-310. [5] Sanfilippo F,Currò JM,la Via L,et al. Use of nafamostat mesilate for anticoagulation during extracorporeal membrane oxygenation:a systematic review[J]. Artif Organs,2022,46(12):2371-2381. [6] 刘志艳,向倩,崔一民. 甲磺酸萘莫司他临床应用的研究现状[J]. 中国临床药理学杂志,2020,36(15):2368-2372. Liu ZY,Xiang Q,Cui YM.Research status of clinical application of nafamostatmesilate[J]. Chin J Clin Pharmacol,2020,36(15):2368-2372. [7] Davenport A.What are the anticoagulation options for intermittent hemodialysis?[J]. Nat Rev Nephrol,2011,7(9):499-508. [8] Marasco SF,Lukas G,McDonald M,et al. Review of ECMO (extra corporeal membrane oxygenation)support in critically ill adult patients[J]. Heart Lung Circ,2008,17(Suppl 4):S41-S47. [9] Lang YH,Zheng Y,Qi BC,et al.Anticoagulation with nafamostat mesilate during extracorporeal life support[J]. Int J Cardiol,2022,366:71-79. [10] Esper SA,Levy JH,Waters JH,et al.Extracorporeal membrane oxygenation in the adult:a review of anticoagulation monitoring and transfusion[J]. Anesth Analg,2014,118(4):731-743. [11] 司向,管向东. 体外膜肺氧合抗凝管理现状和挑战[J]. 中华医学杂志,2022,102(25):1864-1869. Si X,Guan XD.Current status and challenges of anticoagulation management in extracorporeal membrane oxygenation[J]. Natl Med J China,2022,102(25):1864-1869. [12] Liu Y,Yuan ZY,Han XN,et al.A comparison of activated par-tial thromboplastin time and activated coagulation time for anticoagulation monitoring during extracorporeal membrane oxygenation therapy[J]. Hamostaseologie,2022:1-8. [13] 吕芳芳,殷静静,杨丽娟. 肺切除术后胸腔引流管管理的最佳证据总结[J]. 中华护理杂志,2020,55(5):773-779. Lü FF,Yin JJ,Yang LJ.Summary of the best evidence for nursing management of thoracic drainage tube after pneumonectomy[J]. Chin J Nurs,2020,55(5):773-779. [14] 王宁夫. 体外膜氧合器使用中严重并发症的防治[J]. 中华心血管病杂志,2020,48(6):431-433. Wang NF.Prevention and intervention of major complications during application of extracorporeal membrane oxygenation[J]. Chin J Cardiol,2020,48(6):431-433. [15] 吴月,徐胜玲,吴华堂. 1例ECMO技术抢救新型冠状病毒肺炎合并感染性休克老年病人的护理[J]. 护理研究,2020,34(7):1130-1133. Wu Y,Xu SL,Wu HT.Nursing care of a patient with COVID-19 complicated with septic shock treated with ECMO[J]. Chin Nurs Res,2020,34(7):1130-1133. [16] 罗小龙,黄亮,李洋. 清醒状态下体外膜肺氧合治疗的研究进展[J]. 中华急诊医学杂志,2020,29(7):1007-1010. Luo XL,Huang L,Li Y.Research progress of extracorporeal membrane oxygenation in awake state[J]. Chin J Emerg Med,2020,29(7):1007-1010. [17] 中华医学会急诊医学分会复苏学组,成人体外心肺复苏专家共识组. 成人体外心肺复苏专家共识[J]. 中华急诊医学杂志,2018,27(1):22-29. Resuscitation Group of Emergency Medicine Branch of Chinese Medical Association,Expert Consensus Group of Adult CPR. Expert consensus on adult cardiopulmonary resuscitation[J]. Chin J Emerg Med,2018,27(1):22-29. [18] 廉波,陈彧,赵舟,等. 插管策略对静-动脉体外膜式氧合相关并发症的影响:单中心回顾性研究[J]. 中国循环杂志,2018, 33(4):380-384. Lian B,Chen Y,Zhao Z,et al.Impact of cannulation strategies on veno-arterial extracorporeal membrane oxygenation complications—a single center retrospective study[J]. Chin Circ J,2018,33(4):380-384. [19] Chanan EL,Bingham N,Smith DE,et al.Early detection,prevention,and management of acute limb ischemia in adults supported with venoarterial extracorporeal membrane oxygenation[J]. J Cardiothorac Vasc Anesth,2020,34(11):3125-3132. |